Novel 4-drug combination proves safe for lung cancer treatment
Thursday, November 13, 2008 - 13:14
in Health & Medicine
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center.
Read the whole article on Physorg
More from Physorg
Related
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- New treatment combination proves safe, effective for head and neck cancer patientsMon, 2 Jun 2008, 17:14:58 EDT
- New treatment combination safe for pancreatic cancer patientsMon, 2 Jun 2008, 9:22:00 EDT
- Study shows drug combination improves outcome for advanced non-small cell lung cancerSat, 30 May 2009, 11:29:37 EDT